Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer (NCT03655015)

🧪 Interventions in This Study

• Lung Tumor Resection (PROCEDURE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• UT Health San Antonio, M.D. Anderson Cancer Center — San Antonio, Texas

📞 Contact the Study Coordinator

Phone: (210) 450-8234

Email: tavernaj@uthscsa.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Lung Neoplasm

• Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules — Aurora, Colorado
• Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma — Sacramento, California
• Patient Reported Outcomes Following Percutaneous Lung Ablation — Rochester, Minnesota
• Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy — Long Beach, California
• Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I) — Lexington, Kentucky

Explore by condition: All Lung Neoplasm clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.